We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An analysis of seven international clinical trials published yesterday found that corticosteroids help reduce the risk of death in the most severe COVID-19 patients. Read More
Sanofi and Regeneron Pharmaceuticals said they have no plans to conduct further trials of their rheumatoid arthritis drug Kevzara for COVID-19 after it failed in a late-stage study. Read More
In applications for patents — including some generally relevant to its COVID-19 vaccine candidate — Moderna failed to disclose millions of dollars it got from the Defense Advanced Research Projects Agency (DARPA), alleges an advocacy group that wants the Department of Defense (DOD) to investigate. Read More
GlaxoSmithKline failed yesterday to convince an FDA advisory committee that it should be allowed to add study data showing a reduction in mortality to the label of its chronic obstructive pulmonary disease (COPD) drug Trelegy Ellipta. Read More
GlaxoSmithKline and Vir Biotechnology have dosed the first patient in a phase 2/3 clinical trial of their investigational COVID-19 antibody treatment VIR-7831 for early treatment in patients at high risk of hospitalization. Read More
Johnson & Johnson (J&J) says it will begin a phase 2 trial of its COVID-19 vaccine candidate in Spain, Germany and the Netherlands this week. Read More
J&J previously announced that it expects to begin a phase 3 trial of its vaccine candidate, Ad26.COV2.S, in 60,000 participants in early September. Read More
President Trump vowed during his acceptance speech at the Republican National Convention that a coronavirus vaccine will be ready by the end of the year even as many experts continue to express skepticism about such an expedited timeline. Read More
Ology Bioservices, an Alachua, Fla.-based biologics contract development and manufacturing organization (CDMO), has been granted a contract worth up to $106.3 million from the U.S. Army to help out with COVID-19 vaccine and therapeutic production. Read More